Literature DB >> 7578049

Heparinase I from Flavobacterium heparinum: the role of the cysteine residue in catalysis as probed by chemical modification and site-directed mutagenesis.

R Sasisekharan1, D Leckband, R Godavarti, G Venkataraman, C L Cooney, R Langer.   

Abstract

Heparinase I (heparin lyase I, EC 4.2.2.7), a heparin-degrading enzyme produced by Flavobacterium heparinum, is used to deheparinize blood following extracorporeal procedures in surgery and in other applications. The present study of mapping and characterization of the cysteines of heparinase I represents the first structural characterization of a heparinase. [3H]Iodoacetic acid labeling demonstrated that heparinase I has two free cysteines. One of the two cysteines is surface accessible and lies in a hydrophilic environment while the other is in a hydrophobic environment. Chemical modification of the cysteines, both in the presence and in the absence of heparin, suggests that the surface-accessible cysteine lies in or near the active site of heparinase I. Preferential reactivity of this cysteine with negatively charged sulfhydryl-modifying reagents and the cysteines' high reactivity to iodoacetic acid at pH 6.5 indicate that the surface-accessible cysteine is in a positively charged region. The surface-accessible cysteine (cysteine-135) was mapped as the active-site cysteine by radiolabeling with [3H]iodoacetic acid and by tryptic digestion and peptide sequencing. Site-directed mutagenesis of cysteine-135 to a serine or an alanine in r-heparinase I demonstrates that this cysteine is essential for enzymatic activity. However, replacement of the surface-inaccessible cysteine by a serine or alanine has no effect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7578049     DOI: 10.1021/bi00044a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.

Authors:  S Ernst; A J Rhomberg; K Biemann; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

2.  Heparin/heparan sulfate N-sulfamidase from Flavobacterium heparinum: structural and biochemical investigation of catalytic nitrogen-sulfur bond cleavage.

Authors:  James R Myette; Venkataramanan Soundararajan; Jonathan Behr; Zachary Shriver; Rahul Raman; Ram Sasisekharan
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

3.  Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum.

Authors:  S Ernst; G Venkataraman; S Winkler; R Godavarti; R Langer; C L Cooney; R Sasisekharan
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

4.  High yield, purity and activity of soluble recombinant Bacteroides thetaiotaomicron GST-heparinase I from Escherichia coli.

Authors:  Yongde Luo; Xinqiang Huang; Wallace L McKeehan
Journal:  Arch Biochem Biophys       Date:  2007-02-16       Impact factor: 4.013

5.  A highly active heparinase I from Bacteroides cellulosilyticus: Cloning, high level expression, and molecular characterization.

Authors:  Li-Wei Gao; Hong-Tao Zhu; Cai-Yun Liu; Zhi-Xiang Lv; Xiao-Man Fan; Ye-Wang Zhang
Journal:  PLoS One       Date:  2020-10-20       Impact factor: 3.240

6.  Probiotics in human gut microbiota can degrade host glycosaminoglycans.

Authors:  Keigo Kawai; Reiko Kamochi; Sayoko Oiki; Kousaku Murata; Wataru Hashimoto
Journal:  Sci Rep       Date:  2018-07-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.